Scegli un formato
CHF 223.00
CHF 732.00
CHF 223.00
Informazioni su questo articolo
Vai a
Nome del prodotto
Adenosine 5′-triphosphate, periodate oxidized sodium salt, ≥97%
SMILES string
[Na].Nc1ncnc2n(cnc12)[C@H](O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C=O)C=O
InChI key
IHQATUPGVKMGLT-AUCRBCQYSA-N
InChI
1S/C10H14N5O13P3.Na.H/c11-9-8-10(13-4-12-9)15(5-14-8)7(2-17)26-6(1-16)3-25-30(21,22)28-31(23,24)27-29(18,19)20;;/h1-2,4-7H,3H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;/t6-,7+;;/m0../s1
biological source
bacterial (corynebacterium sp)
assay
≥97%
form
powder
storage temp.
−20°C
Quality Level
Categorie correlate
1 of 4
Questo articolo | |||
|---|---|---|---|
| biological source bacterial (corynebacterium sp) | biological source - | biological source - | biological source synthetic (organic) |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| assay ≥97% | assay 90-95% | assay ≥95% | assay ≥93% |
| form powder | form solid | form powder | form powder |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
General description
Application
- as an antagonist of the purinergic receptor, P2 × 7 to inhibit P2 × 7 pathway[2]
- as a nonspecific agonist to assess the activity of P2×7-R by the mobilization of Ca2+[3]
- to evaluate the physiological significance of elevated intracellular ATP levels
- increased P2rx7 expression for osteoclastogenesis in Flcn-deficient cells[4]
Biochem/physiol Actions
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Active Filters
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica


